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Abstract—The premises made in this paper put the future of 
personalisation in epilepsy into focus, a focus that shifts from a 
one-size fits all to a focus on the core of the epilepsy patients’ 
individual characteristics. The emerging approach of 
personalised healthcare is known to be facilitated by the Internet 
of Things (IoT) and sensor-based IoT devices are in popular 
demand for healthcare providers due to the constant need for 
patient monitoring. In epilepsy, the most common and complex 
patients to deal with correspond to those with multiple strands of 
epilepsy. These extremely varied kind of patients should be 
monitored precisely according to their identified key symptoms 
and specific characteristics then treatment tailored accordingly. 
Consequently, paradigms are needed to personalise this 
information. By focusing upon personalised parameters that 
make epilepsy patients distinct this paper proposes an IoT based 
Epilepsy monitoring model endorsing a more accurate and 
refined way of remotely monitoring the ‘individual’ patient. 
Keywords—IoT; healthcare systems; smart healthcare; 
personalisation 
I. INTRODUCTION 
By integrating IoT sensor-based devices deployed remotely 
and personalised patient data into a combined monitoring 
framework a vision of personalisation is realised. This study 
revealed some irrefutable evidence derived from patient profile 
analysis and experimental data that seizure detection using 
sensors positioned on different parts of a patents body 
ultimately makes an impact on the monitoring of epilepsy, 
endorsing that modern computer science is providing a timely 
chance for a more personalised approach to the monitoring and 
management of epilepsy. 
The chances of capturing seizure data can be greatly 
increased if a correctly assigned sensor is placed on the correct 
part of the patient’s body and ultimately, such a concept could 
‘enhance the overall monitoring scheme of a patient usually 
performed by caring persons, who might occasionally miss an 
epileptic event’ [1]. 
This paper is organised as follows. In section II and section 
III the state of the art is analysed; the complexity of epilepsy 
together with smart healthcare monitoring approaches are 
highlighted. There is also a focus upon the sensors available for 
epilepsy following on with an emphasis on the limitations for a 
personalised approach. Section IV presents the driving 
questions in this study and describes the experiment and 
findings from capturing seizure data. Section V introduces the 
proposed IoT based Epilepsy monitoring model and reveals the 
PMP (Personalised Monitoring Plan) framework whereby the 
patient can be matched with the correct device, while Section 
VI presents how this was evaluated and Section VII outlines 
long term use. Concluding remarks are drawn in Section VIII. 
II. MOTIVATION 
Epileptic seizure monitoring and management is 
challenging. Most current studies of epileptic seizure detection 
disclose drug resistant epilepsy still lacks an ultimate solution, 
despite the increase in anti-epileptic drugs [2]. 
Epilepsy is not a single disease, but a family of syndromes 
that share the feature of recurring seizures. In some instances, it 
may be related to a genetic aetiology, or it can occur in 
association with metabolic disorders, structural abnormalities, 
infection or brain injury [3]. 
In the United Kingdom epilepsy affects 3 million people 
and in the United States it is the 4th most common neurologic 
disorder, only migraine, stroke, and Alzheimer’s disease occurs 
more frequently [4]. There are around 60 different types of 
seizure and a person may have more than one type. Seizures 
vary depending on where in the brain they are happening. 
Some people remain aware throughout, while others can lose 
consciousness [5]. 
Aside from their unpredictability, the worst part of having 
seizures is their utter complexity. The complex nature of 
epilepsy is noticeable in the variation of seizures types and 
symptoms between one patient and another. Distinguishing or 
classifying an individual epilepsy patient makes it difficult to 
manage and monitor. The negative impact of uncontrolled 
seizures spreads beyond the individual to affect their family, 
friends, and society. Chronic anxiety is experienced by the 
families and friends of people with epilepsy and many lives are 
adjusted to ensure the safety of their loved one. Novel 
approaches to epilepsy treatment are still greatly needed [6] 
novel therapies that better manage and monitor seizures as well 
as technology can help to handle the consequences of seizures. 
Insufficient knowledge about epilepsy, which is a very 
common disorder, has a great and negative impact on people 
with epilepsy, their families and communities, and the 
healthcare systems. There is need for a better understanding of 
the disease to make way for new approaches to monitor it. 
In the modern day of personalised medicine and rapid 
advancements in IoT a question that needs addressing is 
whether epilepsy monitoring can benefit from personalised 
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approach. Can the IoT have the potential to significantly 
improve the ‘patients’ daily lives whose seizures cannot be 
controlled by either drugs or surgery [7]? 
A. Smart Healthcare Monitoring Approaches 
In the history of time it is only relatively recently that 
computers began to assist healthcare monitoring, in 1950s’ 
patients began to be continuously monitored by computerised 
machines [8] and clinical monitoring was first envisaged in the 
home [9]. For computer assistance to epilepsy it was not until 
1972 in the field of imaging, when computerized tomography 
(CT) was invented by the British engineer Godfrey Hounsfield 
[10] and only in recent decades where specific epilepsy 
healthcare ‘monitoring systems’ have been proposed. 
Much of this recent growth being due to the advent of 
current IoT technology whereby the rise of ‘smart 
environment’ approaches to healthcare monitoring is 
witnessed. There are many IoT approaches for the monitoring 
and management of epilepsy many of which encompass a 
network of connected smart devices which are equipped with 
sensors either embedded in clothing or smart phones, to either 
detect, predict or manage epilepsy. Discoveries disclose how 
IoT is utilised to support the ever-growing trend of 
personalised healthcare. These recent ‘smart’ approaches in 
healthcare demonstrate the trend toward ‘sensor use’ and 
‘remote monitoring’. 
III. RELATED WORK 
Researchers are bounding toward the new generation of 
smart technology and IoT (Internet of Things). Novel devices 
such as smart watches, smart bands & smart clothing are all 
competing for the ultimate solution. Yet it is found there is 
limited research which focuses upon the concept of a more 
holistic, personalised approach to help manage epilepsy. 
One study deemed the significance of attention on smart 
technologies and its potential to identify early indicators of 
cognitive and physical illness [11] and observed that 
researchers have argued and predicted that assessing 
individuals in their ‘everyday environment’ will provide the 
most ‘valid’ information about everyday functional status [12]. 
Indeed, there is evidence recently of this indication as 
several IoT platforms to manage & monitor healthcare 
remotely, are observed. For example, one IoT paradigm 
comprising of Wireless Health Sensors (WHS) permits the 
continuous monitoring of biometric parameters such as pulse 
rate, pulmonary functional quality, blood pressure and body 
temperature [13]. This IoT paradigm is being used to assist 
predictive analysis via smart healthcare systems by a medical 
practitioner. Using sensors connected to Arduino patient status 
is tracked, and by a Wi-fi connection data is collected and 
transmitted and can receive user requests. This data is shared 
with doctors through a website where the doctor can analyse 
the condition of the patient and provide further details online 
and intimate patient about future severity well in time [13]. 
A. Sensors for Epilepsy 
EEG, an electroencephalogram is a recording of brain 
activity. This is the chief gold standard method used within 
hospitals to detect and monitor seizures. Several approaches 
have been reported with the aim to embed this method in other 
settings and platforms. Developments in some topics have been 
published, such as modelling the recorded signals [14] [15] or 
the design of portable EEG devices to deploy such models. 
As an alternative and sometimes supplement to EEG there 
exist many sensors embedded in clothing or worn on the body 
to obtain bio-signals such as gyroscopes, accelerometers, pulse 
rate, temperature sensors, magnetometers, galvanic skin 
response sensors (GSR), implanted advisory system, 
electromyography, video detection systems, mattress sensor, 
and audio systems [16]. 
A large amount of apps have been published more recently 
especially in the commercial sector for the detection and 
management of seizures using either the Smartphone sensors or 
external sensors, for example Epdetec [17] and Myepipal [18] 
and web logging which facilitates the way a patient records 
daily information concerning her/his epileptic events, 
medication, and news, My Epilepsy Diary [19] and Epidiary 
[20] . Another app attracting attention and recently reviewed in 
the press is the Alert App by Empatica. This app sends 
caregivers an automated SMS and phone call when it detects 
unusual patterns that may be associated to a convulsive seizure 
[21] yet it is only designed to work with the Embrace 
Smartband by Empatica and can prove expensive for the user 
[22]. 
Regrettably, there are few specific sensor detection options 
for each specific seizure type, this is an imminent requirement 
for patients and their carers. Ideally when choosing a seizure 
detection device, the patient-specific seizure semiology’s 
should be considered [16]. Thus, highlighting the need for a 
type of monitoring that distinguishes one patient from another 
and depicting the need for devices to pinpoint the patient-
specific signs and symptoms. 
B. Addressing the Gaps 
Despite the focus in literature on smart healthcare 
monitoring approaches there is limited emphasis on the 
embracing of a truly personalised approach for epilepsy as 
previously described. Even though the ‘diversity’ of epilepsy is 
acknowledged and has been identified in other studies, i.e. by 
highlighting the importance of distinguishing each ‘seizure 
type’, there is still a gap to address such parameters. The 
‘seizure type’ is just one of many parameters that can 
distinguish one seizure patient from another. Therefore, these 
very individual characteristics can be further identified to 
address the challenge to achieve a truly personalised approach 
to managing epilepsy. 
More so recently it is recognised that devices should 
specially take into account the user’s seizure types and 
personal preferences [23], focus should be shifting not only on 
the desires of the users but seizure detection devices should be 
able to ‘adapt’ to the patient’s characteristics and seizures [23]. 
It is already becoming known that wearing sensors on the 
body is starting to be popular, as observed recently in a 2018 
study where a great interest was highlighted in the use of 
wearable technology for epilepsy carers, this being 
independent of demographic and clinical factors and 
remarkably outpacing data security and technology usability 
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concerns thus demonstrating the vital factor of comfortability 
[24]. Yet as discovered during a review to select the best sensor 
for each individual patient there was limited data on which was 
the best sensor for each seizure type, this was unfortunate 
despite an internationally active research effort, signifying the 
gap in knowledge, again, for understanding the individual 
epilepsy patient [16]. 
IV. EXPERIEMNT AND FINDINGS 
This section discusses the experiment that was performed 
to capture seizure data, obtained from sensors, which are 
positioned on different parts of the patient’s body. This was 
done to test the assumption that it is ‘the individual profile’ that 
makes the difference in which device to choose. The results 
from this experiment are used to inform a typical model or a 
PMP (Personalised Monitoring Plan) discussed in the next 
section. 
The actual ‘sensor’, and their ‘position’ (worn by the 
patient) are significant for epilepsy and the focus in the 
experiment was on how patients exhibit behaviour, rather than 
any actual testing of devices. It was therefore important to 
choose the most accurate sensors for monitoring epilepsy; 
those were found to be the accelerometer and heart-rate 
sensors, although latest studies suggest making use of other 
sensors too such as peripheral temperature, photo 
plethysmography (blood circulation), respiratory sensors [25], 
and galvanic (changes in sweat gland activity) among others 
[26]. 
A. Preliminary Investigations 
Numerous studies have been previously been conducted 
with sensors and use for epilepsy [27] [28]. Since the ‘gold 
standard’ for epilepsy monitoring is video-EEG monitoring 
(which takes place within hospitals) [29] the driving questions 
addressed here were: 
1) Can the patient be just as accurately monitored at home 
with an inexpensive, easily obtainable accelerometer and 
heart-rate sensor-based device? 
2) Can the individual requirements of the patient be 
pinpointed? If so, is it possible that these sensors can be worn 
at home (a personalised approach) and be just as effective as 
using EEG monitoring in the hospital setting? 
From the analysis of the patient data it is clear that a patient 
profile based on particular characteristics can indicate which 
position the sensor is best placed on the patient’s body. 
Sample patient profiles where selected based upon criteria 
informed from discussions with clinicians. For example, 
Patient Profile 1 seizures begins with the right arm suddenly 
raising, therefore can the sensor be placed upon the right 
shoulder? Patient Profile 4 has a lot of shaking during their 
Focal Onset Seizures with shaking starting on the left arm so 
therefore can the sensor be useful attached to the left wrist? 
Whereas Patient Profile 5 begins their seizures with severe 
tremors on the right leg, can the sensors detect movement and 
heart-rate changes with sensor in this position? 
During the investigation practicable devices to use in the 
experiment to monitor epilepsy were analysed. The ‘Fitbit 
Ionic’ was chosen as the best option since both the heart-rate 
and accelerometer can be extracted. The commercial activity 
device has been used in other studies, most notably recently 
whereby it used data from more than 47,000 Fitbit users in five 
U.S. states and data revealed that with Fitbit use the state-wide 
predictions of flu outbreaks were enhanced and accelerated 
[30]. This use demonstrates the viability and potential 
suitability of Fitbit as a healthcare device. 
B. Experimental Description 
The objectives of the experiment were to assess the 
movement from the accelerometer sensor and the pulse from 
the heart-rate sensor in the detection of epileptic seizures. 
Participants with confirmed epilepsy are recruited. The non-
invasive wrist, leg, knee or arm-worn sensors are used to 
acquire heart-rate activity and movements. The study evaluated 
the movement from the accelerometer sensor and the pulse 
from the heart-rate sensor in the detection of an epileptic 
seizure. Over a period of 5 days the patients were asked to 
wear the device and continue recording seizures in their seizure 
diary. The study also evaluated any differences in result due to 
the ‘position’ of the sensor on the body together with the 
patients’ acceptability & comfort. 
The instructions contained daily forms for the patient to 
complete, hence, keeping a diary of the times of seizure, if they 
did not use this method an EEG recording was obtained. This 
way the actual time stamp of the patients recorded seizure can 
be checked against the server time stamp observations of the 
seizure, so for example if the patient records their seizure at 
10.20am and the server readings reveal heart-rate peaks and 
rapid movement from the accelerometer also at 10.20am, then 
this confirms the server readings match the patients (or EEG) 
known seizure occurrence, see Fig. 1, Seizure Time Stamps. 
C. Experimental Results 
The heart-rate and accelerometer sensors used to detect 
characteristics of seizure events can successfully record seizure 
data, without need for participant cooperation beyond wearing 
the sensor-based device, even recharging the battery (battery 
life is 5 days when fully charged) was not required by the 
participants. Both the sensors detected the ‘shaking’ seizures 
correctly as can be seen in observation d HP4, in Fig. 2, 
Observations, set 1. 
The effectiveness was also verified by “Non-seizure times” 
which are more easily recognised in sleep due to inactivity 
demonstrating that the sensors worked properly: see the above 
random time periods, in Fig. 2 whereby seizures did not occur 
for HP4 in Observation ‘k’ and ‘i’. 
 
Fig. 1. Seizure Time Stamps. 
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Fig. 2. Observations, Set 1. 
Both accelerometer and heart-rate sensors have been used 
to detect seizures in numerous previous studies [25] but in this 
study it was found that when used together in one device they 
did not always work in sync “together”. This is because when 
the sensors were worn on the non-dominant side and a seizure 
occurs only the heart-rate change was indicated: the 
accelerometer showed no change. Yet when in correct position 
on the body they work in union as an excellent detection 
method. Therefore, demonstrating that body placement or 
position is paramount. For example, one patient’s dominant 
side was the right arm. This means seizures are known to occur 
on the right. The results from “Observation c HP4” (Fig.2), can 
be seen. During shaking from the right wrist at the recorded 
time: 00.23am during a GTCS seizure all 3 measurements on 
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axis X, Y and Z showed sudden movements and the heart-rate 
increased to its highest peak at 128. Before the seizure the 
heart-rate was much lower at 80, then rising rapidly to 90 and 
up to 128. This suggests both the sensors detected the seizure 
correctly. 
Yet the results from “Observation a HP4”, seen below in 
Fig. 3, Observation Set 2 indicate that during a GTCS at the 
recorded time ‘12.44pm’ the 3 measurements on axis X, Y and 
Z did not show any sudden movement, in fact barely any 
movement at all, yet the heart-rate increased to its highest peak 
at 124, in keeping with typical heart-rate increase measurement 
during a GTCS for HP4. Since the accelerometer was 
positioned on the left wrist this reveals the sensor did not detect 
movement therefore demonstrating the sensor was positioned 
in the wrong position. 
Knowing the individual characteristics of the patient profile 
prior to sensor-based device recommendation is key, for 
example the HP1 with FAS (Focal Aware Seizures) and FSIA. 
(Focal Seizures with Impaired Awareness): the question 
here was “did the 2 sensors work in union to detect the Focal 
seizures?” Some heart-rate increase was detected but the 
accelerometer was primarily redundant, for example in 
‘Observation 10’ (Fig.3.) a seizure occurs with sensor 
positioned on right wrist at the observed time: 09.44am, in this 
observation the heart-rate sensor detects some change over a 2 
minute period i.e. The heart-rate begins at 87 increases to 90 
then back to 87 then declines to 86 then steadily back to 90. At 
09.45am the heart-rate does show increase to 95 and goes back 
down to 85. Heart-rate range is 87 -95, with some sudden 
movement from accelerometer at time of increased heart-rate. 
Yet, during ‘Observation 11’, seen in Fig. 3 for HP1 with 
the seizure observed at 20.36pm the heart-rate range is 81-84 
with little sudden movement. Likewise, in ‘Observation 12’ 
(Fig. 4, Observations set 3) seen above: the seizure occurrence 





Fig. 3. Observations, Set 2. 
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A pattern emerges for HP1 in other observations whereby 
the heart-rate decreases, for example in ‘Observation a HP1’ 
(in Fig. 4.) above at the time of the seizure ‘09.55am’ the heart-
rate decreases from 90 to 84, and likewise in ‘Observation f 
HP1’ (Fig.4) with heart-rate decrease from 104 to 79 during the 
observed time of seizure at 11.01am and in ‘Observation g 
HP1’ (Fig.4) with heart-rate decrease from 100 to 84 during the 
observed time of seizure at 20.44pm. 
In ‘Observation g HP1’ the accelerometer indicates 
movement from all 3 X, Y and Z axis on the accelerometer at 
the time of the seizure. This is further observed in ‘Observation 
e HP1’ (Fig. 5, Observations, set 4) whereby there is sudden 
change in the accelerometer, but this is ‘21.01pm’ ‘after’ the 






Fig. 4. Observations, Set 3. 
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Fig. 5. Observations, Set 4. 
Only 1/14 seizures observed for HP1 demonstrate 
significant movement for the accelerometer during seizures. 
Therefore, the accelerometer sensor is not useful for detecting 
these non-shaking seizures, although some patients’ profiles 
(found earlier in the collection of the ‘anonymous patient 
profiles’) reveal absence seizures can evolve to convulsive 
generalized tonic clonic movements. Therefore, it is endorsed 
that Focal seizures alone, go undetected without HR changes 
[31]. 
Predominantly during non-seizure time periods for HP1 
there is no significant variance in accelerometer measurements 
when compared to ‘seizure occurrence’ time periods. For 
example, “Observation 16” (Fig. 5) shows a 4-minute snap-
shot when HP1 has no seizure: the 3 axis X, Y and Z move 
similarly in “Observation 12” (Fig. 5). 
Ultimately there is some evidence demonstrated here that 
heart-rate ‘change’ occurs during the seizures for HP1 
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(increase and decrease). Yet since the seizures for HP1 occur 
for such a short time (20 seconds) heart-rate fluctuations can be 
missed or miss-interpreted as ‘false alarms’ perhaps due to 
agitation before or after the seizure. 
The key and common signs and symptoms are ‘LOC’ (Loss 
of Consciousness) and ‘Automatisms’ for a patient such as 
HP1. Automatisms reveal themselves in a multitude of forms 
including repetitive movements, such as, lip smacking, 
chewing or swallowing, picking at clothes or skin or even 
staring [32] and these are difficult to detect with any sensor. 
Hence, these repetitive movements deemed as other 
behavioural components of seizures which include non-motor 
components and post-ictal phenomena cannot be detected by 
the accelerometer [33] in line with the theory that seizures that 
are typical to the dominant body area not wearing the sensor-
based device will not be detected. 
Some patients exhibit automatisms such as sudden 
sweating events [34] and since sweating is associated with 
Focal Seizures a more appropriate sensor for a patient with 
FAS and FSIA seizure types would be Galvanic Skin Response 
Sensor (GSR), which refers to changes in sweat gland activity 
[35] as evidenced in other studies performed to detect seizures 
this galvanic skin response (GSR) sensor has been used in 
multi-modal platforms [34]. 
Empaticas’ ‘Embrace Plus’ smart watch [35] can be useful 
for Focal seizures as it has other sensors in addition to 
Galvanic Skin Response (GSR), for example EDA sensor and 
peripheral temperature, are just one of many sensors available 
in this device for researchers [36]. The Electro Dermal Activity 
(EDA )  represents the electrical changes on the surface of the 
skin (not just for sweat). Although witnessed in some studies 
finding that EDA increases during GTCS were greater than 
during CPS (Complex Partial Seizure, now: focal seizure with 
loss of consciousness) nonetheless it is a useful sensor for this 
type of seizure [36]. 
The peripheral temperature sensor also has evidence for use 
in detection in non-convulsive seizure’s (CPS) (focal) [36]. 
Although the Fitbit Ionic used in this study is not a 
conventional device for monitoring epilepsy, it can be adapted 
to detect seizures as demonstrated. It is a less expensive 
everyday ‘patient friendly’ option as opposed to EEG 
monitoring whereby the patient wears electrodes that are not 
comfortable: this is because the EEG-electrodes must be 
attached to the scalp which hampers the patient's movement 
making long-term home monitoring not feasible. 
In this sense this less expensive, comfortable alternative to 
EEG monitoring can be especially useful for patients with non-
epileptic events. During early analysis in this experiment many 
patient profiles (found in the collected ‘anonymous patient 
profiles’) where identified as having non-epileptic events and 
were categorised under “Non-Classified”. Although no 
confirmed ‘epilepsy’ these patients are still suffering with 
seizure signs and symptoms: as observed below in ‘HP5. 
Observation 1’ (Fig. 5). This patient has a non-epileptic 
shaking event at 23:03pm, the observation indicates heart-rate 
increase from 80 up to 109, the accelerometer also indicates 
rapid activity at the time of the shaking event. 
One of the challenges in using sensor-based IoT devices to 
achieve a personalised approach is the barriers found in the use 
of them in hospital settings. Although EEG monitoring is the 
chief gold standard method used within hospitals to detect and 
monitor seizures, there is limited evidence found how sensor-
based IoT devices and experiments are used in hospital 
settings. 
There are very few experiments with sensor-based IoT 
devices that have been endorsed by the hospitals and a large 
problem is poor information when caring for people with 
epilepsy or doing epilepsy clinical trials [37] yet there is great 
potential to vastly increase the efficacy of epilepsy 
management using biomedical devices that can improve the 
quality of information. As available devices and sensors grow, 
if clinicians could be provided with more guidance in 
understanding and choosing which sensor suits which situation 
then a personalised approach can be achieved. 
D. Calibration 
Prior to this experiment upon hospital patients, this study 
was conducted with 2 non-epileptic volunteers who were asked 
to undergo the testing and perform ‘simulated seizures’ in a 
controlled environment with the sensor-based device 
positioned on different parts of the body at different times of 
the day. This was to calibrate the main hospital patient 
experiments. The findings are discussed below, with evidence 
of some of the Volunteer Observations together with the 
simulated individual profile characteristics and criteria used for 
observations. 
As can be seen from ‘V1.Observation 1’ in Fig.5. 
Volunteer Observations, set 1, below, the first volunteer, with 
seizures occurring on the dominant right side of the body 
simulated a GTCS shaking from the right arm at the recorded 
time: 20.38pm. The sensor-based device was worn on the right 
wrist. The 3 measurements on axis X, Y and Z showed sudden 
movement and the heart-rate increased to its highest peak at 
100. Before the seizure the heart-rate was steadier at 78-81, 
then after the seizure the heart-rate decreased to 80. This 
suggested the sensors detected the simulated seizure correctly. 
When V1 simulated a seizure again from the right arm they 
placed the sensor-based device on the left wrist at the event 
time: 10.10am. As identified in ‘V1. Observation 3’ (Fig. 6) 
the heart-rate shows an increase (78 to 123) yet the 
accelerometer axis is smooth. Similarly, in ‘V1. Observation 4’ 
(Fig.6.) the volunteer placed the device on the ‘non-dominant’ 
left leg and again the heart-rate increased dramatically but the 
acceleration generally smooth, although some movement on all 
3 axis at the time: 09.47am of the event. Since ‘some 
movement’ was detected here a further test was performed with 
the device on the dominant right leg and here the difference is 
apparent, seen in V1. Observation 5 in Fig.7. This confirms the 
theory identified in earlier hospital patient observations that the 
sensor-based device position is paramount. 
For V2 the dominant side is left. It is evident when V2 
placed the sensor-based device on the left leg during a 
simulated seizure at 22.14pm both the heart-rate and 
accelerometer sensors are reacting vigorously, seen in 
‘V2.Observation 1’ in Fig. 7. 
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Similar to V1 when V2 places the sensor-based device on 
the ‘non-dominant’ side (right leg) during a simulated seizure 
only the heart-rate sensor reacts, seen below in 
‘V2.Observation 1a’ (Fig. 7) again fueling the theory that 
‘position’ of the sensor-based device is paramount. 
E. Known Characteristics 
Detection of seizures using an everyday sensor-based 
device and data transfer to online database was successful. This 
presented evidence that remote monitoring of specific epilepsy 
patients’ profiles with known characteristics can be improved. 
The comfortable sensor-based device with heart-rate and 
accelerometer provided accurate data and is a more dependable 
method than a patient’s paper diary. 
Difference was observed due to ‘position’ on the body of 
the sensor-based device, demonstrating that because of the 
known patient specific characteristics a personalised approach 
is achieved. Furthermore, it was discovered that the ‘type’ of 
sensor used is principal in its correspondence with a patients’ 
particular ‘seizure type’ together with the particular associated 
signs or symptoms. 
The sensors and techniques used in this experiment enable 
some assurance in long term remote monitoring. The use of 
such sensor-based device used in this experiment can reduce 
the frequency of visits to hospitals and improve daily 
management of epilepsy thus, these sensing techniques have 
shown that results can be achieved in the measurement of 
specific epileptic seizures based on observations. 
As established through these experiments’ timely detection 





Fig. 6. Volunteer Observations, Set 1. 
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Fig. 7. Volunteer Observations, Set 2. 
  
(IJACSA) International Journal of Advanced Computer Science and Applications, 
Vol. 12, No. 9, 2021 
38 | P a g e  
www.ijacsa.thesai.org 
V. IOT BASED EPILEPSY MONITORING MODEL 
The purpose of the IoT based Epilepsy monitoring model 
[38] is to support a ‘Personalised Monitoring Plan’ framework 
in collecting data from a variety of potential epilepsy device 
sensors and also provide optimal analysis tools to utilise the 
sensor data thus supporting clinicians to monitor epilepsy 
patients. 
A. PMP Framework 
This section proposes a Personalised Monitoring Plan 
(PMP) framework. In the previous section experiments were 
performed to capture seizure data, obtained from sensors, 
which are positioned on different parts of the patient’s body. 
The results from this experiment are used to inform a PMP 
(Personalised Monitoring Plan), seen below in Fig. 8 which 
recommends which sensor-based device to use based on those 
very individual, personal characteristics of a given patient. 
The proposed ‘Personalised Monitoring Plan’ (PMP) 
framework is a model for which doctors and healthcare 
professionals (HCPs) can use to assist in identifying which 
device they should recommend to the individual patient for 
remote monitoring. 
The PMP framework integrates two types of 
‘personalisation: 
 The patient as the individual (derived from an ontology 
language). 
 Use Patients in a category (using the K-means 
Clustering method). 
Both these personalisation elements are described below in 
in the next sections. The third tool of the PMP framework 
supports the decisions surrounding recommending the correct 
IoT sensor-based devices. The main purpose is to help HCPs 
decide which IoT Sensors to recommend for monitoring and 
which position on the patient’s body. 
The PMP framework ultimately allows users to provide a 
description of the ‘seizure condition’ of a single patient or a 
patient type, and to automatically obtain a PMP adjusted to the 
patient requirements. 
The proposed framework consists of two features: the first 
being ‘Personalisation’ (based on this study) and the second is 
the anticipated ‘Remote Monitoring’, shown in pink and blue 
respectively in Fig. 8, PMP Framework. 
B. Personalisation Elements 
The personalisation contributions are part of the preceding 
findings in this study. The ontology language was created to 
support the need of the healthcare process to transmit, re-use 
and share individual patient profile data related to their 
seizures. 
The ontology was achieved by the initial examination of 
100 anonymous epilepsy patient medical records. The data was 
analysed to discover if values for each of the attributes are 
different for each patient, together with the investigation of 
epilepsy ‘terminology’ and existing seizure type 
classifications/categories were analysed so that an ‘individual’ 
seizure type patient profile could be formed. A close 
collaboration with clinicians helped to build a data model fit 
for real-world adoption inside hospital settings and thus an 
ontology was developed to model the concept of the epilepsy 
patient profile, namely ESO ‘Epilepsy Seizure Ontology’. This 
was a driving force for the PMP Framework and a critical 
aspect for this concept. In order to make ESO useable for 
HCPs (Health Care Professionals) the ontology was 
transformed into a language that is understandable by humans 
and machines, this was accomplished by XML and the 
outcome was PPDL (Patient Profile Description Language). 
 
Fig. 8. PMP Framework. 
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The second personalisation element was achieved by using 
K-means Clustering analysis. Different clustering techniques 
were initially analysed to find the most appropriate approach 
for the acquired epilepsy data and an in-depth focus upon 
‘clustering considerations’ was undertaken to confirm validity. 
The outcome was a set of 6 distinct ‘clustering’ groups, 
shown in Table I. These 6 cluster groups revealed six 
completely different categories of patients each with their 
distinct seizure related information. 
The results revealed the distinct groups of epilepsy patients 
that share similar characteristics using Clustering Analysis. 
This will enable the health carers to define a ‘type’ of epilepsy 
patient. 
C. PMP Framework Loop and Maintenance 
With this PMP framework, the PPDL (Patient Profile 
Description Language) can be directly maintained (and 
extended) by HCP’s. The framework has the flexibility, (as the 
ontology grows with new seizure related concepts), to deal 
with the mounting diversity of seizure type patients. Therefore, 
the PMP framework is somewhat reliant on the integration of 
new knowledge in the PPDL. As the HCP of the PMP 
Framework approves the recommendations, the information 
about the patient and the advice may change and this new 
information can cause the PMP Framework to continue 
providing new suggestions to the HCP. 
This loop will stop either when the framework is not able to 
provide new recommendations or when the HCP considers that 
the current condition of the patient is correctly represented by 
the recommendation. At any time, the PMP for the patient is 
fundamentally controlled by the HCP who is using the 
framework. 
Consequently both the personalised ‘seizure related data’ 
and the ‘cluster classifier data’ of a patient may evolve as the 
patient disorder changes, for example when the information 
about the patient changes in the patient record of that patient or 
as a result of the application of the PMP Framework to find out 
new ‘seizure type’ knowledge about the current patient. The 
datasets are expected to evolve and are continuously stored as 
part of the record of that patient. 
D. IoT based Epilepsy Monitoring Model 
To achieve the type of monitoring described in the PMP 
framework, several IoT components can be deployed to 
retrieve sensor data from the epilepsy patient to be accessed 
remotely. These components include the integration of the 
personalisation components described in the PMP framework, 
those of an internet connection and protocols which form the 
‘network layer’, a cloud platform to manage the data analysis 
and fundamentally the sensor-based devices forming the sensor 
layer. These components make the ingredients of an IoT 
solution, proposed in the IoT based Epilepsy monitoring model 
shown in Fig. 9. 
The sensor layer, (discussed in section F) has the task of 
acquiring and sending the data from the different epilepsy 
devices involved in capturing seizure data, to the proposed 
cloud platform. 
The ‘IoT based Epilepsy monitoring model’ proposal in 
Fig.9 shows areas on the body where parameters are measured, 
each area is indicated with a colour matching the parameter. 
E. Cloud Platform 
The proposed cloud platform provides all the necessary 
services for the clinician to manage, process and visualise the 
seizure data. All the processes that involve the interaction 
between the personalisation layer and the sensor layer are 
carried out through the following modules: PMP data 
management, machine learning module and data analysis & 
visualisation. All these services are hosted in the cloud and 
clinicians are able to access them remotely from any location. 
The data analysis and visualisation module utilises the 
sensor data while the ‘PMP data management’ module pulls all 
the patient records from the personalisation modules and here 
the sensor data results are updated. Visualisation is a 
requirement for any such system as it is important for clinicians 
to be provided with user friendly GUIs so they can study the 
seizure data from the epilepsy sensor devices. The machine 
learning module is also proposed, this is a key aspect for future 
development and the idea is that by using algorithms the 
module will ‘learn’ when a patient is about to have seizure and 
warn them in advance. 
TABLE I. CLUSTER GROUPS 
Attribute Cluster      
 Cluster 0 Cluster 1 Cluster 2 Cluster 3 Cluster 4 Cluster 5 
Seizure Type NMA Un-classified FAS Gelastic GTCS  
Key Sign / 
Symptoms 









None   LOC LOC 





Automatism Automatism Sensory Cognitive Automatism 
Arm / Leg Either Leg Either Either Leg Either 
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Fig. 9. IoT based Epilepsy Monitoring Model. 
A pre-processing hardware and a platform are needed to 
communicate and transmit the sensor data which is collected 
using wearable sensors positioned on a patient’s body. The 
Microsoft Azure IoT platform [39] is proposed, since this 
cloud computing server is trusted and safe [40]. 
F. Sensor Layer 
The sensor layer has the task of acquiring and sending the 
data from the different epilepsy devices involved in capturing 
seizure data, to the proposed cloud platform. 
The sensors previously used in the experiment, the heart-
rate and accelerometer sensors were demonstrated within the 
PMP framework discussed in this paper. Yet there are other 
sensors too that can work within the context of this research. 
These potential sensors found in other devices are explored and 
proposed below. 
Despite the expense, multi-modal sensor based devices are 
the ultimate desire to monitor an epilepsy patients seizures 
since multiple sensors are embedded in one device and make 
comfortability for the patient and all-in-one solutions for the 
manager of the device, furthermore epilepsy patients have 
revealed their preference for devices capable of monitoring 
several parameters [24]. Section III in this paper uncovered 
some of the epilepsy detection devices and monitoring systems, 
whilst section IV demonstrated the use of an inexpensive 
device with heart-rate and accelerometer sensor (justified for 
experimental purposes), and simultaneously identified other 
useful sensors for epilepsy. These other sensors which exist in 
devices, those that go beyond heart and movement sensing, and 
beyond fitness devices, are amongst a vast amount. 
Consequently, many studies have analysed the performance 
and limitations of each sensor based device, one critical 
evaluation by Peake [41] found many devices where not yet 
fully validated or tested for reliability, therefore this 
examination will aim only to propose validated devices for use 
in the IoT based Epilepsy monitoring model. 
Recently in 2020, Abreu, Fred et al [42] did a significant 
exploration on, wearables and related devices, that can be 
utilised for epilepsy prediction, the findings presents devices, 
some with multiple sensors, characterised with respect to their 
applicability to research, validation status, form factor or body 
positioning, battery duration, method to access the data, 
measured signals and, their applicability to epilepsy prediction 
(EP) [42]. This is a vital study since the devices have already 
been validated, and connectivity options identified, and since 
they are beneficial for epilepsy they can be proposed in the IoT 
based Epilepsy monitoring model. 
These devices and their sensors, identified as applicable for 
epilepsy prediction contain some of the sensors that were 
highlighted during the experiments i.e. accelerometer, heart-
rate and GSR, but the audio and bladder sensors were not 
previously included. In this case the audio and bladder are 
added to the IoT based Epilepsy monitoring model in Fig.9 
above and the connectivity options and battery life can be 
referred to in Table II. 
The IoT based Epilepsy monitoring model proposal in 
Fig.9 shows areas on the body where parameters are measured, 
each area is indicated with a colour matching the parameter. 
The chosen devices have been proposed based upon the factors 
in the study by Abreu, Fred et al [42] for the best battery life, 
validity, and connectivity options selected for ease of 
connection to the cloud platform in the IoT based Epilepsy 
monitoring model. Since Embrace2 device uses its own 
onboard processing it is not adaptable for the model proposed 
in this study. Furthermore some of the device based sensors 
depicted in 
Table II. ‘Selected Sensors’ are multi-modal so their use 
can sometimes be proposed in more than one activity area, for 
example the device EQ02 has both the heart-rate and 
temperature sensor. 
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TABLE II. SELECTED SENSORS 
Body Area Validated Device Sensor Connectivity Option Battery Life 
Breathing HexoSkin RESP Cloud Storage or BLE transmission 12h 
Electrodermal Empatica E4 EDA or GVS Cloud Storage 48h 
Blood Volume Empatica E4 PPG Cloud Storage 48h 
Movement Bioharness3 ACC BLE transmission 12-24h 
Heart-Rate EQ02 ECG Bluetooth transmission 48h 
Temperature EQ02 Temp Bluetooth transmission 48h 
Audio Alert-it Sound Sensor Ethernet connection 12-16h 
Bladder/ Incontinence DFree Ultra- sound Bluetooth transmission 24h 
G. Network Layer 
There are several ways the sensors can connect and send 
data to the cloud platform and since most of the sensor devices 
connect to a mobile phone they are served by Bluetooth or 
Bluetooth Low Energy (BLE) and use very little power. 
Nevertheless, each sensor-based device is provided with its 
own protocol and connectivity options, hence the type of IoT 
connectivity is determined generally by the distance that the 
data must travel, either short-range or long-range [43]. IoT 
platforms such as Azure use gateways to connect IoT devices 
to the cloud. The data collected from the devices moves 
through this gateway, gets pre-processed using in build 
modules (Edge) and then gets sent to the cloud. Data is 
protected by an additional layer of security provided by the 
Azure Application gateway and in addition connection security 
is enabled as each connected IoT device is given a unique 
identity key [39]. 
VI. EVALUATION 
An evaluation was performed by taking two different 
epilepsy patients through the steps in the PMP framework. 
Two different ‘use case’ scenarios each with different patient 
profiles were tested by revealing their respective inputs and 
outputs. The aim was to provide the Personalised Monitoring 
Plan (PMP) described in this study and only the ‘seizure 
related’ information of the patient was considered. This input 
data is primarily composed of the patients’ seizure types, signs 
and symptoms. Therefore, given the condition of an epilepsy 
patient, the PMP is used to personalise the medical knowledge 
available for that patient, all other unrelated medical 
knowledge to the patient is discarded. The input data was 
processed using the framework features: in summary the 
framework produced new datasets that were passed to the 
‘Generate PMP’ component, these were: seizure profiler data, 
cluster classifier data and sensor position information. The 
evaluation results helped determine the effectiveness of the 
PMP framework and how it can be used as a tool for 
recommending the IoT device to an epilepsy individual patient. 
VII. LONG TERM USES AND APPLICABILITY IN OTHER 
DOMAINS 
The methods used in this study for ontology development 
and clustering analysis can be applied to any disease whereby 
recognised symptoms per patient can be individualised and be 
further put into sub-groups or categories. However, to fully 
utilise this personalised approach the application of the PMP 
framework can be particularly applied to patients whom have 
symptoms that can be monitored with different IoT sensor-
based devices and personalised further by wearing the device 
on different body positions. In the future the following types of 
patients can be handled by the proposed PMP framework: 
(shown below together with latest progressive recommended 
sensor-based devices). 
 Diabetes: i.e. One such recommended device could be 
use of ‘flash glucose sensing’: A device which checks 
blood glucose levels by scanning a sensor worn on their 
arm will be (available on the NHS for people with type 
1 diabetes) [44]. 
 Sick Infants: i.e. A recommended device could be use 
of a miniaturised, wireless oxygen sensor wearable 
device the size of a Band-Aid which would allow 
babies to be monitored from home and able to leave the 
hospital [45]. 
 Rehabilitation: i.e. the recommended device for 
rehabilitation could be a Force-based sensor which can 
be integrated with footwear to measure the interaction 
of the body with the ground during walking [36]. Due 
to the possibility of detecting not only physiological but 
also movement data wearable sensors have also 
acquired increasing importance in the field of 
rehabilitation [46]. 
A. Machine Learning 
Another significant future direction for long-term remote 
monitoring of epilepsy is seizure detection via ‘machine 
learning’. By accumulating large datasets, computers can learn 
by recognising patterns in data. 
This automated approach (without human intervention) has 
been proposed as a ‘machine learning module’ within the PMP 
framework and IoT based Epilepsy monitoring model to 
determine seizure detection or not based on the patient specific 
profile, the idea being that by using algorithms the module will 
‘learn’ when a patient is about to have seizure and warn them 
in advance. Due to limitations in this study this module has not 
been built but instead is proposed at the next stage and 
recommended for the next level. Largely there is further work 
to take the PMP conceptual model and the IoT based Epilepsy 
monitoring model into full operation. 
Recent advances in machine learning and deep learning 
technique inventions have shown noteworthy advantage in the 
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automatic learning of robust features that outperformed the 
human oriented features in many domains such as self-driving 
cars, natural language processing, and computer vision also 
medical diagnosis [47] [48]. 
Yet as identified in a review of epileptic seizure detection 
using machine learning classifiers a major challenge is to 
detect seizures correctly from a large volume of data [49], and 
it is highlighted that the selection of suitable classifiers and 
features are crucial [49]. 
Ultimately, along with the challenges associated with the 
increasing dataset sizes (hence growing epilepsy cases), and 
evolving date science hitches, as well as obtaining sensitive 
data it could be argued that the greatest challenge of all to help 
solve these problems is the enabling collaboration between 
people with differences in expertise [50]. 
VIII. CONCLUSION 
The principal contribution in this study was that with the 
prior ‘knowledge’ of individual patient characteristics drawn 
from the PPDL repository and ‘Cluster Groups’ together with 
the supplementary ‘proof of concept’ knowledge obtained in 
the experiments each epilepsy patient can be treated distinctly 
and recommended an appropriate sensor-based device thus 
forming a patient specific unique PMP (Personalised 
Monitoring Plan). Hence personalisation can be achieved. 
The sensors and techniques used in the experiment enables 
some assurance in long term remote monitoring. The use of 
such sensor-based device used in the experiment can reduce the 
frequency of visits to hospitals and improve daily management 
of epilepsy thus, these sensing techniques have shown that 
results can be achieved in the measurement of specific epileptic 
seizures based on observations. 
As established through these experiments’ timely detection 
along with known patient characteristics is one of the keys to 
monitoring epilepsy. 
The integration of the components and technologies in the 
framework depicted in Fig.8 PMP Framework aims at 
providing HCP’s dealing with epilepsy patients with an 
integrated tool that helps them in recommending the correct 
IoT sensor and position on the patient’s body. 
These decisions are made at the initial consultation and act 
as an ‘aid’ in personalising the condition of new incoming 
patients, and thus refine the predefined ‘patient record’ in order 
to obtain and validate a ‘Personalised Monitoring Plan’ which 
is in addition adapted to include the seizure monitoring of the 
patient during appointments. 
The PMP Framework is designed to provide a patient-
empowering support in a way that the available knowledge is 
continuously personalised to the condition of the seizure type 
patient. The IoT based Epilepsy monitoring model has been 
proposed and can be adopted by the PMP framework in future 
developments. 
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